COVID-19 Updates and Information from Department of Pathology and Cell Biology
Search All News
NIH is giving out funds to develop seven new testing technologies which could increase testing capacity around the U.S. Daniel Green, MD, was quoted in this article about the RADx program.
They gave scientific presentations covering COVID-19 and non-COVID-19 basic science topics as well as their most current research.
Source:CISION PR Newswire
Kedrion Biopharma, a leading international biopharmaceutical company, partners with Columbia University Irving Medical Center to accelerate the development of an anti-COVID IgG therapy.
Source:CBC NewsApril 13, 2020
Convalescent plasma has been given to a small number of patients in the U.S. hoping it might help them fight off the virus. But the research is at early stages.
Source:Shrink Speak with Dr. LiebermanApril 8, 2020
Dr. Eldad Hod talks on his efforts to implement serological testing to identify patients who have recovered from COVID-19 and who may qualify as convalescent plasma donors.
Source:ABC Eyewitness NewsApril 7, 2020
"This is bigger than us all, so we're trying to do what we can," said Dr. Eldad Hod, "I've been working on this 24/7 for the past three weeks."
Source:CUIMC NewsroomMarch 31, 2020
Pathology laboratory screened New York state’s first potential donor—a COVID-19 survivor for antibodies that can be used to treat or vaccine against COVID-19.
Source:CBS New YorkMarch 31, 2020
Dr. Eldad Hod talks on CBS on harnessing COVID-19 survirors' antibodies to fight the coronavirus disease in others.
Source:CUIMC NewsroomFebruary 24, 2020
A team led by Pathology researcher, Alex Chavez, MD, PhD, will use a new drug screening approach to rapidly screen a large number of compounds that block the protease of 2019-nCoV.